Lifecare ASA is a Norwegian medical technology company founded in 2006 and headquartered in Bergen, Norway. The company specializes in developing sensor technologies for the continuous monitoring of body analytes, particularly glucose levels in humans and pets with diabetes. Lifecare ASA’s main product is the Sencell, a 3D-printed nano-sensor that allows for continuous glucose monitoring (CGM) and can detect various analytes and molecules in the body. In addition to glucose monitoring solutions, the company also focuses on medical devices aimed at the removal of subdermal implants. As of August 25, 2026, Lifecare ASA has a market capitalization of approximately 121.7 million NOK and employs around 25 people. In October 2024, the company received approval for its shares to be listed on Euronext Oslo Børs, a notable milestone in its corporate development. As of August 26, 2026, Lifecare ASA's stock is trading at 0.29 NOK per share.
AI-researched from public web sources, not from the exchange listing itself — may contain errors or omissions and is not a substitute for verifying independently.
Lifecare ASA's offering is currently approved on OTHER. Lifecare ASA is headquartered in Norway. It is classified under Biotech.
Other IPOs DiscoverIPO tracks that share a sector, market, or underwriter with Lifecare ASA.
Drop a live deal card into your own site — works in WordPress, Ghost, Notion, Webflow, and any self-hosted page that allows an <iframe>. It does not work in Substack or in an emailed newsletter — no email client, and Substack itself, supports arbitrary iframes. For those, use the share image or the attribution text below instead.
<iframe src="https://www.discoveripo.com/embed/lifecare-asa" width="100%" height="300" style="border:0;max-width:560px" loading="lazy" title="Lifecare ASA — DiscoverIPO"></iframe>
Dark by default. For a light background, use https://www.discoveripo.com/embed/lifecare-asa?theme=light as the src instead.
https://www.discoveripo.com/ipo/lifecare-asa/opengraph-image
Lifecare ASA IPO details — tracked by DiscoverIPO: https://www.discoveripo.com/ipo/lifecare-asa?utm_source=embed&utm_medium=text&utm_campaign=lifecare-asa
Get emailed when Lifecare ASA's terms, price, or expected date change — no weekly noise, just this company.
Lifecare ASA is listing on OTHER.
Lifecare ASA is a Norwegian medical technology company founded in 2006 and headquartered in Bergen, Norway. The company specializes in developing sensor technologies for the continuous monitoring of body analytes, particularly glucose levels in humans and pets with diabetes. Lifecare ASA’s main product is the Sencell, a 3D-printed nano-sensor that allows for continuous glucose monitoring (CGM) and can detect various analytes and molecules in the body. In addition to glucose monitoring solutions, the company also focuses on medical devices aimed at the removal of subdermal implants. As of August 25, 2026, Lifecare ASA has a market capitalization of approximately 121.7 million NOK and employs around 25 people. In October 2024, the company received approval for its shares to be listed on Euronext Oslo Børs, a notable milestone in its corporate development. As of August 26, 2026, Lifecare ASA's stock is trading at 0.29 NOK per share.
European Securities and Markets Authority's Prospectus Regulation register — a prospectus approval date, not a confirmed listing date. Retrieved Aug 26, 2026.
View the original filing on ESMA →Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public filings and exchange calendars, may be incomplete or out of date, and should be verified against the original source before you act on them.
We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy